EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

HOXD13-mediated immune crosstalk between cancer cells and tumor-associated macrophages drives colorectal cancer progression

Xilang Chen, Jie Chen, Yue Yin, Mengyu Sun, Siwen Li, Jiaqian Zhang, Zhangfan Wu, Junqing Jiang, Dian Hu, Daiming Fan, Yongzhan Nie, Wenjie Huang und 2 weitere

Journal for ImmunoTherapy of Cancer · 2026

DOI: 10.1136/jitc-2025-014028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2026. Verfasst von Xilang Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xij…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Homeodomain Proteins, Tumor-Associated Macrophages, Transcription Factors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, The State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, The Noncommunicable Chronic Diseases-National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The complex tumor microenvironment (TME) of colorectal cancer (CRC), composed of diverse cellular components and dynamic interactions, constitutes a major barrier to effective immunotherapy and facilitates disease progression. There is a pressing need to elucidate CRC-intrinsic factors that induce the immunosuppressive TME. Here, we explored the role of homeobox D13 (HOXD13) in shaping the immune microenvironment of CRC and its contribution to immunosuppression.

Methods

The expression level of HOXD13 was assessed using quantitative real-time PCR, immunoblotting, and immunohistochemistry. The role of HOXD13 in CRC was investigated using orthotopic allograft models and azoxymethane/dextran sulfate sodium-induced spontaneous tumor models in intestine-specific HOXD13 knockout and knock-in mice. The immune landscape of the CRC microenvironment was characterized via flow cytometry and immunofluorescence.

Results

Our study revealed the upregulation mechanism of HOXD13 in CRC and its functional role in fostering an immunosuppressive TME. HOXD13 was upregulated in CRC, particularly in metastatic cases, and patients exhibiting high HOXD13 expression showed poorer clinical outcomes. Mechanistically, HOXD13 promoted M2-type polarization of tumor-associated macrophages (TAMs) and suppressed CD8 + T cells mediated antitumor immunity by transcriptionally upregulating amphiregulin (AREG) and paired immunoglobulin like type 2 receptor alpha (PILRA) in CRC cells. Concurrently, transforming growth factor beta 1 released from M2-polarized TAMs further augmented HOXD13 expression in CRC cells via activation of the Smad2/3 signaling pathway. This reciprocal interaction formed a self-reinforcing loop that sustained immunosuppression and thereby accelerated tumor progression. Notably, combined inhibition of AREG and programmed cell death ligand 1 effectively disrupted this crosstalk, restored antitumor immunity, and ultimately suppressed CRC progression.

Conclusions

Our study identified HOXD13 as a pivotal regulator in the establishment of an immunosuppressive TME and suggested that targeting the HOXD13 signaling axis represents a promising strategy to sensitize CRC to immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsHomeodomain ProteinsTumor-Associated MacrophagesTranscription FactorsAnimalsHumansMiceTumor MicroenvironmentDisease ProgressionCell Line, TumorFemaleSignal Transduction

Stichwörter der Autor:innen

Colorectal CancerImmunotherapyMacrophageTumor microenvironment - TME

Substanzen

Homeodomain ProteinsTranscription Factors

Autor:innen und Institutionen

  • State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University…
  • Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji Hospital of Tongji Medical College, Huazhong University of Science and…
  • Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases; Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Clinical Medicine Research Center for Hepatic Su…

Förderung

  • National Natural Science Foundation of China
  • The State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers
  • The Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • The Basic Research Support Program of Huazhong University of Science and Technology

Zitieren

APA

Chen, X., Chen, J., Yin, Y., Sun, M., Li, S., Zhang, J., Wu, Z., Jiang, J., Hu, D., Fan, D., Nie, Y., Huang, W., Wu, K., & Xia, L. (2026). HOXD13-mediated immune crosstalk between cancer cells and tumor-associated macrophages drives colorectal cancer progression. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2025-014028

Vancouver

Chen X, Chen J, Yin Y, Sun M, Li S, Zhang J, et al. HOXD13-mediated immune crosstalk between cancer cells and tumor-associated macrophages drives colorectal cancer progression. Journal for ImmunoTherapy of Cancer. 2026. doi:10.1136/jitc-2025-014028

BibTeX
@article{Chen2026,
  author = {Chen, Xilang and Chen, Jie and Yin, Yue and Sun, Mengyu and Li, Siwen and Zhang, Jiaqian and Wu, Zhangfan and Jiang, Junqing and Hu, Dian and Fan, Daiming and Nie, Yongzhan and Huang, Wenjie and Wu, Kaichun and Xia, Limin},
  title = {HOXD13-mediated immune crosstalk between cancer cells and tumor-associated macrophages drives colorectal cancer progression},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  doi = {10.1136/jitc-2025-014028}
}
Kostenlos starten →